Alex Herrera, MD

Hematologist/oncologist, and assistant professor, Department of Hematology and Hematopoietic Cell Transplantation, City of Hope

Articles by Alex Herrera, MD

CAR T as Frontline Therapy for DLBC Lymphoma: Alex Herrera, MD

ByAlex Herrera, MD

September 28th 2021

The hematologist/oncologist from City of Hope discussed the potential for CAR T-cell therapy in earlier lines of treatment for patients with diffuse large B-cell lymphoma.

CAR T-Cell Utility in Hematologic Cancers: Alex Herrera, MD

ByAlex Herrera, MD

September 13th 2021

The hematologist and oncologist from City of Hope discussed the utility of CAR T cells in patients with hematologic cancers.

Alex Herrera, MD

Articles by Alex Herrera, MD

CAR T as Frontline Therapy for DLBC Lymphoma: Alex Herrera, MD

CAR T-Cell Utility in Hematologic Cancers: Alex Herrera, MD

Latest Updated Articles

Trending on CGTlive®

What Were the Most Significant Inflection Points or Breakthroughs in Cell and Gene Therapy?

Around the Helix: Cell and Gene Therapy Company Updates – November 5, 2025

Evaluating CAR-T KYV-101 for Generalized Myasthenia Gravis

Guess the Therapy Answer November 5, 2025